Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
Sheikh Qassem: Resistance is a source of power for Lebanon that must be preserved.
Sheikh Qassem: "Israel" must implement the agreement as Lebanon has already done so, and any new accord would amount to absolving it and opening the door to further attacks.
Sheikh Qassem: We do not wish to assume anyone's role; those accusing us of this must cease their accusations.
Sheikh Qassem: We will recover our lands through national solidarity; Resistance's goal is national liberation, while enemy goal is occupation.
Sheikh Qassem: Protection of sovereignty protects Lebanon. It is in real danger because of US belligerence, greedy Israeli expansion.
Qassem to Lebanese people: We are not asking for support but for us not to be stabbed in the back in the back or for some to serve Israeli interests; government is primary party responsible for [preservation of] sovereignty.
Sheikh Qassem: "Israel" can occupy, but it cannot persist in occupation of our land.
Sheikh Qassem: Intimidation will not change our stance of resistance and steadfastness. We are not advocates of surrender or defeat, and we will never accept it.
Sheikh Qassem: Where does US stand regarding enemy's unjustified assassination of a government worker and other civilian martyrs?
Sheikh Qassem: Is the Lebanese Army's defense of its land and citizens an accusation [leveled against it]? Where does US stand regarding the enemy's killing of civilians and constant destruction?

Trump, AstraZeneca announce US drug pricing deal at White House

  • By Al Mayadeen English
  • Source: News websites
  • 11 Oct 2025 15:09
  • 1 Shares
3 Min Read

AstraZeneca set to sell some medicines at lower prices through Medicaid and a new TrumpRx platform in return for a three-year US tariff exemption.

Listen
  • x
  • Trump, AstraZeneca announce US drug pricing deal at White House
    US President Donald Trump speaks in the Oval Office of the White House, on October 10, 2025, in Washington, as Health and Human Services Secretary Robert F. Kennedy Jr. and Dr. Marty Makary, commissioner of the Food and Drug Administration, listen. (AP Photo/Alex Brandon)

US President Donald Trump announced a new agreement on Friday with UK-based pharmaceutical company AstraZeneca, under which the company will provide discounted medicines through the Medicaid health program in exchange for a three-year tariff exemption. The deal follows a similar agreement reached earlier with Pfizer.

The Trump administration announced that the deal forms part of a broader effort to pressure pharmaceutical companies to reduce drug prices for US consumers, who pay the highest prescription drug prices in the developed world.

As part of the agreement, AstraZeneca will offer certain medications at up to 80% off their list prices through a planned online platform called TrumpRx, which is expected to launch next year. AstraZeneca CEO Pascal Soriot confirmed the company would provide these discounts while benefiting from temporary tariff exemptions to localize the remainder of its product portfolio.

In recent months, Trump intensified pressure on major drugmakers, threatening 100% tariffs on imported medications if companies failed to reduce prices or shift production to the US. Letters sent in July to 17 major pharmaceutical firms demanded price cuts, with AstraZeneca and Pfizer being the first to reach a formal agreement with the administration.

According to the White House, the framework established by these deals will be used to expand similar agreements across the pharmaceutical sector.

Related News

Republican lawmakers question Trump plan to sell Alaskan LNG to China

US aggression endangers Lebanon’s sovereignty, Sheikh Qassem says

Experts question real impact on US healthcare costs

While the administration touted the deal as a step toward lowering consumer costs, experts expressed skepticism over its actual impact, especially within Medicaid, the joint federal-state health program for low-income Americans, which already receives the lowest drug prices in the country.

Craig Garthwaite, a professor at Northwestern University, said AstraZeneca’s drug portfolio does not suggest a major price shift is likely for Medicaid. "I don't think there are a bunch of drugs that exist where that's going to involve them giving a very big discount," he said.

Rena Conti, a health policy expert at Boston University, added that while the deal may benefit the company by avoiding tariffs, its effect on out-of-pocket costs and rising insurance premiums remains limited. "It’s good for the companies, and has very uncertain, if any, benefit for Americans struggling with the affordability of prescription drugs," she noted.

AstraZeneca has increasingly sought to strengthen its ties with the US market. In July, the company announced a $50 billion investment plan to expand manufacturing and R&D across six states, including what will become its largest site globally in Virginia.

In a separate move responding to pricing pressure, the company also pledged in September to sell its diabetes and asthma medications directly to US patients at discounts of up to 70% for those paying out of pocket.

Moreover, CEO Pascal Soriot has emphasized the company’s shift in identity toward its largest market. “We are a very American company,” he said, noting plans to list AstraZeneca shares on US stock exchanges in addition to those in the UK and Europe.

  • United States
  • AstraZeneca
  • Donald Trump
  • TrumpRx
  • white house

Most Read

Arab League chief exposes secret US deal shielding 'Israel’s' nukes

Arab League chief exposes secret US deal shielding 'Israel’s' nukes

  • Politics
  • 27 Oct 2025
Hi-tech holocaust: Microsoft’s role in Gaza genocide

Microsoft's role in world’s first AI-driven genocide, in Gaza, exposed

  • Technology
  • 28 Oct 2025
Sheikh Naim Qassem speaks during an interview with Al-Manar TV, October 26, 2025 (Screenshot)

Hezbollah ready to face 'Israel' in case of war: Sheikh Naim Qassem

  • Politics
  • 27 Oct 2025
The secret cloud deal: Google and Amazon “winking” pact with 'Israel'

With a 'wink', Israeli control over Google, Amazon cloud data exposed

  • Technology
  • 29 Oct 2025

Coverage

All
War on Gaza

Read Next

All
ap
Politics

Hamas calls on int’l community to act against Israeli settlement plan

In this Nov. 9, 2017, file photo, U.S. President Donald Trump, right, chats with Chinese President Xi Jinping during a welcome ceremony at the Great Hall of the People in Beijing. (AP)
Economy

Ex-US diplomat says Trump-Xi deal 'tactical retreat', not lasting deal

An unarmed Minuteman II intercontinental ballistic missile launches from Vandenberg Air Force Base, California, during a test in 2002. (US Air Force)
Politics

JD Vance defends Trump's nuclear test plan as 'crucial for security'

Ultra-Orthodox Jews attend the "million man" protest against military conscription, in occupied al-Quds, October 30, 2025 (AFP)
Politics

Haredi mass rally in al-Quds exposes Zionist regime's growing crisis

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS